Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST‐MST): study protocol for a randomized non‐inferiority trial of magnetic seizure therapy versus electroconvulsive therapy

Open access

Published version of a preprint

Abstract

Background: Electroconvulsive therapy (ECT) is well-established and effective for treatment-resistant depression (TRD), but in Canada and the USA, less than 1% of patients with TRD receive ECT mainly due to its cognitive adverse effects (i.e. amnesia). Thus, new treatment alternatives for TRD are urgently needed. One such treatment is magnetic seizure therapy (MST). ECT involves applying a train of high-frequency electrical stimuli to induce a seizure, whereas MST involves applying a train of high-frequency magnetic stimuli to induce a seizure. Methods: In this manuscript, we introduce our international, two-site, double-blinded, randomized, non-inferiority clinical trial to develop MST as an effective and safe treatment for TRD. This trial will compare the efficacy of MST to right unilateral ultra-brief pulse width electroconvulsive therapy (RUL-UB-ECT) with a combined primary endpoint of remission of depression and superior cognitive adverse effects in 260 patients with TRD. Amelioration of suicidal ideation will be assessed as a secondary endpoint. Inpatients or outpatients, over 18 years of age with a MINI International Neuropsychiatric Interview (MINI) diagnosis of non-psychotic major depressive disorder (MDD) can be enrolled in the study provided that they meet illness severity and full eligibility criteria. Participants are randomized to receive MST or RUL-UB ECT, 2-3 days per week over seven weeks, or a maximum of 21 treatments. The study will involve before-, during-, and after-treatment assessments of depression severity, suicidal ideation, subjective side-effects, and cognitive performance consistent with an intent-to-treat study design approach. Discussion: Positive results from this trial could have an immediate and tremendous impact for patients with TRD. If MST demonstrates comparable antidepressant treatment efficacy to ECT, but with greater cognitive safety, it could rapidly be adopted into clinical practice. Indeed, given that the administration of MST is nearly identical to ECT, the majority of ECT facilities in North America could readily adopt MST. Furthermore, the potential for cognitive safety could lead to improved treatment acceptability. Healthcare providers, patients and care partners, and policymakers would therefore demand this form of convulsive therapy. Trial status: Enrollment for this study began on June 26, 2018, and is estimated to complete recruitment by July 2024. At the time of submission, we have enrolled and randomized 117 participants. Trial registration: ClinicalTrials.gov NCT03191058 , Registered on June 19, 2017. Primary sponsor: Daniel Blumberger (DMB), Principal Investigator Daniel.Blumberger@camh.ca, 416-535-8501 x 33662 Contact for public queries: DMB, Daniel.Blumberger@camh.ca Contact for scientific queries: ZJD, Zdaskalakis@health.ucsd.edu

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13063-021-05730-7

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Study design
Fig. 1 Study designCC BY · PubMed Central
Fig. 2 MagPro XP with Cool Twin Coil (MagVenture A/S, Farum, Denmark)
Fig. 2 MagPro XP with Cool Twin Coil (MagVenture A/S, Farum, Denmark)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 63 references

Cited by

See all 26

Metadata

Authors
Daskalakis, Z. J., Tamminga, C., Throop, A., Palmer, L., Dimitrova, J., Farzan, F., Thorpe, K. E., McClintock, S. M., & Blumberger, D. M.
Affiliations
  • University of California San Diego (US)
  • The University of Texas Southwestern Medical Center (US)
  • University at Buffalo, State University of New York (US)
  • Simon Fraser University (CA)
  • St. Michael's Hospital (CA)
  • Centre for Addiction and Mental Health (CA)
Corresponding author
Daskalakis, Zafiris J.
Venue
Trials
Published
2021-11-08
Volume
22
Issue
1
Pages
786-786
ISSN
1745-6215 (ISSN-L)
OpenAlex
W3158855046
Cited by
23
References
63
Citations by year
2026: 4 · 2025: 2 · 2024: 8 · 2023: 6 · 2022: 2 · 2021: 1
FWCI
3.05
Type
journal article
Language
en
Open access
Licence
Locations
  • Trials (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • TSpace (University of Toronto) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institute of Mental Health (1R01-MH112815)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
magnetic seizure therapy, electroconvulsive therapy, treatment-resistant depression, cognitive side effects, amnesia, suicidal ideation, major depressive disorder, treatment acceptability, Mini International Neuropsychiatric Interview, treatment efficacy and safety
MeSH terms
Equivalence Trials as Topic, Adolescent, Adult, Depression, Major Depressive Disorder, Electroconvulsive Therapy, Humans, Seizures, Treatment Outcome, Depressive Disorder, Treatment-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST‐MST): study protocol for a randomized non‐inferiority trial of magnetic seizure therapy versus electroconvulsive therapy. https://app.cochat.ai/papers/10.1186/s13063-021-05730-7
The paper
Daskalakis, Z. J., Tamminga, C., Throop, A., Palmer, L., Dimitrova, J., Farzan, F., Thorpe, K. E., McClintock, S. M., & Blumberger, D. M. (2021). Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST‐MST): study protocol for a randomized non‐inferiority trial of magnetic seizure therapy versus electroconvulsive therapy. Trials. https://doi.org/10.1186/s13063-021-05730-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.